News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AVANIR Pharmaceuticals (AVNR) to Present at the Seventh Annual JMP Securities Healthcare Conference


7/9/2012 9:51:57 AM

ALISO VIEJO, Calif., July 6, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the Seventh Annual JMP Securities Healthcare Conference.

    • Location: The Peninsula Hotel, New York, NY
    • Presentation date: Thursday July 12, 2012
    • Presentation time: 1:00 p.m. ET

A live webcast and 30-day archive of this presentation will be available at http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIRĀ® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

Ā©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES